UBS O'Connor’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,328
| Closed | -$13.5K | – | 370 |
|
|
2025
Q1 | $13.5K | Sell |
1,328
-104,066
| -99% | -$1.06M | ﹤0.01% | 245 |
|
|
2024
Q4 | $1.47M | Buy |
105,394
+28,672
| +37% | +$400K | 0.04% | 187 |
|
|
2024
Q3 | $1.5M | Buy |
76,722
+7,127
| +10% | +$139K | 0.04% | 215 |
|
|
2024
Q2 | $1.29M | Buy |
69,595
+7,220
| +12% | +$134K | 0.04% | 257 |
|
|
2024
Q1 | $874K | Sell |
62,375
-21,008
| -25% | -$294K | 0.03% | 287 |
|
|
2023
Q4 | $707K | Sell |
83,383
-8,367
| -9% | -$70.9K | 0.02% | 304 |
|
|
2023
Q3 | $820K | Buy |
+91,750
| New | +$820K | 0.01% | 343 |
|